Neuros Medical key facts
as of Oct 2026- Developer of neuromodulation technology designed to develop proprietary therapies for unmet needs in patients worldwide.
- Neuros Medical is valued at approximately $164.0M as of Oct 2026, set at its later-stage round, Jul 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $224.1M across 2 recorded rounds; the latest was Later Stage VC ($56.0M) in Jul 2025.
- Notable investors include United States Department of War, Osage University Partners, Argonautic Ventures, Jumpstart Ventures, JobsOhio Ventures — 29 tracked in total.
- Neuros Medical has filed 2 Form Ds with the SEC since 2023, most recently Aug 2025 ($56.0M sold to 28 investors).
- Status: Privately Held (backing).
Valued at $164.0M at its later-stage round, Jul 2025. Nothing has traded since.
- ·The complete investor list: 29 names
- ·Watch Neuros Medical: the Monday email on marks, rounds and moves
Neuros Medical funding rounds
2 roundsWho backs Neuros Medical
29+Neuros Medical valuation
Neuros Medical was valued at $164 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Neuros Medical raised?
Neuros Medical has raised $224 million in total; 2 of its rounds are on record. The largest on record was a $56 million later-stage round in Jul 2025.
Neuros Medical has filed 2 Form Ds with the SEC since 2023, most recently in Aug 2025 ($56 million sold to 28 investors).
Neuros Medical investors
29 investors are on record for Neuros Medical, including United States Department of War, Osage University Partners, Argonautic Ventures and Jumpstart Ventures. By type, the record holds 6 venture capital firms and 2 family offices. The later-stage round in Jul 2025 drew 28 investors.
About Neuros Medical
Developer of neuromodulation technology designed to develop proprietary therapies for unmet needs in patients worldwide. The company's technology delivers a high-frequency electrical signal to sensory nerves in the peripheral nervous system to block the pain signal and helps in the treatment of chronic pain in a variety of applications, including post-amputation pain, chronic post-surgical pain, and chronic migraine, enabling patients to get relief from pain at an affordable price.
- Sector
- Healthcare
- HQ
- Aliso Viejo, CA, United States
- Founded
- 2008
- Employees
- 43
- Website
- neurosmedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.